| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.09. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 26.08. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 15.07. | iTonic advances AI treatment planning cloud platform development | 1 | Investing.com | ||
| 15.07. | iTonic Holdings Ltd Issues an Update on its Effort to Develop AI-Powered Cloud Healthcare Platform Designed to Support Nuclear Medicine Treatment Planning and with Potential Future Expansion into Digital Care Delivery | 251 | GlobeNewswire (Europe) | New cloud-based platform is being developed to integrate artificial intelligence, automated quality control and healthcare data connectivity to support next-generation precision medicine workflows.... ► Artikel lesen | |
| ITONIC Aktie jetzt für 0€ handeln | |||||
| 23.06. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 13.05. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 24.04. | iTonic Holdings (ITOC) Stock Surges Over 66% After Hours: Why Is It Moving? | 1 | Benzinga.com | ||
| 23.04. | iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule | 323 | GlobeNewswire (Europe) | BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen | |
| 23.04. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 24.03. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 13.01. | Pheton Holdings Ltd. Announces Corporate Name Change and Stock Ticker Symbol Change | 1.010 | GlobeNewswire (Europe) | BEIJING, China, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen | |
| 05.12.25 | Pheton Holdings Ltd. Announces Closing of Share Acquisition with iTonic | 555 | GlobeNewswire (Europe) | Beijing, China, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) ("Pheton" or the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy... ► Artikel lesen | |
| 23.10.25 | Pheton Holdings Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | 863 | GlobeNewswire (Europe) | Beijing, China, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) (the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SENSEONICS | 7,850 | -0,63 % | Senseonics sees activist investor take a major stake | ||
| INCANNEX HEALTHCARE | 3,660 | -3,68 % | Incannex Healthcare: Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X | NEW YORK and MELBOURNE, Australia, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| SRX GLOBAL | 1,610 | +0,62 % | SRX Global Inc: SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company | NORTH PALM BEACH, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the "Company" or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,160 | -2,17 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| FRESENIUS | 46,055 | -0,18 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 11:59... ► Artikel lesen | |
| AETHLON MEDICAL | 6,800 | +375,52 % | Morning Market Movers: AEMD, DAIC, LGVN, DLXY See Big Swings | OTTAWA (dpa-AFX) - At 8:50 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,470 | +0,29 % | BERENBERG stuft Siemens Healthineers auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Siemens Healthineers mit einem Kursziel von 40 Euro auf "Hold" belassen. Der Medizintechnik- und Life-Science-Sektor bleibe fundamental attraktiv... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,960 | +2,87 % | Alignment Healthcare extends retreat, falls an additional 16% | ||
| BETA BIONICS | 21,920 | -1,17 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| GENEDX | 101,91 | +4,54 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| BRIGHTSPRING HEALTH SERVICES | 58,69 | -0,46 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| CARL ZEISS MEDITEC | 29,540 | -2,51 % | EQS-DD: Carl Zeiss Meditec AG: Andreas Pecher, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 15:20... ► Artikel lesen | |
| ESSILORLUXOTTICA | 142,20 | -2,23 % | Wie kommt eine neue Brillentechnologie in einen 160-Milliarden-Dollar-Markt? Warum Vertrieb für kleine Health-Tech-Unternehmen zum entscheidenden Faktor wird | ||
| AVEANNA HEALTHCARE | 14,150 | -0,77 % | Aveanna Healthcare auf dem Deutsche Bank Healthcare Summit 2026: Neuausrichtung auf Wachstumskurs | ||
| HEARTFLOW | 49,625 | +2,68 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen |